Searching Content indexed under Chemicals by McDermott Will & Emery ordered by Published Date Descending.
Links to Result pages
Issues Facing CFCs (Video)
Partners Alexander Lee, Tim Shuman, Britt Haxton and Jay Singer discuss novel concerns facing CFCs in light of Tax Reform.
United States
17 Apr 2018
Raw Materials Compliance
Imagine that you're waiting for an international hop order to clear customs and you receive a panicked call from your broker.
United States
7 Dec 2015
What Comes Next For Mercury Emissions From Power Plants?
The immediate effect of today's decision is that the ongoing challenge to EPA's mercury regulations will be remanded to the U.S. Court of Appeals for the D.C. Circuit, which previously upheld those regulations.
United States
30 Jun 2015
United States To Participate In New World Trade Organization Trade Negotiation To Lower Tariffs On "Green Goods"
The Obama Administration notified Congress of its intent to enter into a new plurilateral trade negotiation to eliminate tariffs on environmental goods.
United States
4 Apr 2014
TSCA Reform in The House & Senate: Extending EPA’s REACH
On July 22, 2010, Representatives Rush (D-IL), Waxman (D-CA), Castor (D-FL), DeGette (D-CO), Schakowsky (D-IL) and Sarbanes (D-MD) introduced the Toxic Chemicals Safety Act of 2010 (TSCA).
United States
19 Aug 2010
REACH Update: Importer Or Only Representative Options For (Pre-)Registration Of Multinational Groups
At the core of the REACH Regulation is the requirement that all substances imported into the European Union (EU) must first be registered with the European Chemicals Agency (ECHA). REACH, however, prescribes that only a company established in the EU can register.
United States
26 Aug 2008
Major Victory On Coverage Under OSHA’s Chemical Process Safety Regulation
McDermott Will & Emery’s OSHA, MSHA & Catastrophe Response Group secured an important victory when it convinced a unanimous U.S.
United States
3 Oct 2006
Discovering the Nucleotide Sequence of a Known DNA Molecule Identifies an Inherent Characteristic of Its Chemical Structure
Affirming a broad claim construction for claims directed to a nucleic acid molecule, the U.S. Court of Appeals for the Federal Circuit upheld a rejection by the U.S. Patent and Trademark Office (USPTO) that the claims were anticipated by earlier publications, which disclosed an uncharacterized form of the nucleic acid.
United States
1 Feb 2005
To Negate Public Use Bar Experimental Use Must Be Limited to Perfecting Claimed Features
Reversing the district court’s erroneous claim construction, the U.S. Court of Appeals for the Federal Circuit held that Apotex’s product infringed SmithKline Beecham’s (now GlaxoSmithKline’s) claim covering the active ingredient of the antidepressant Paxil, but further held the claim invalid because SmithKline’s clinical tests prior to one year before filing constituted a public use not qualifying under the experimental use exception.
United States
26 May 2004
Links to Result pages